- Want to Know Where August Silver Prices Are Headed? Watch the Speculators
- How to Play Gold – So it Doesn't Play You
The insiders just keep buying at our “liquid-biopsy” play TrovaGene Inc. (Nasdaq: TROV).
Shares of the San Diego-based company doubled in just three months after we recommended back on March 11.
When the stock sold off after that skyrocket rally, we told you not to worry. In fact, we recommended you turn that weakness into an opportunity – and accumulate more shares.
The corporate insiders seem to share our confident outlook.
33-year seasoned market analyst and professional trader with highly accurate track record. Specialty in global markets.
35-year expert in oil and gas policy, risk assessment, and emerging market economic development.
30-year CBOE trader, market maker, and retired hedge fund honcho. Helped launch the Volatility Index in 1993.
30-year veteran of tech markets with a Rolodex of Silicon Valley CEOs. Pulitzer nominee. Uncovered rare earths crisis.
30-year veteran analyst of business, economics, and financial markets. Award-winning author of "Contrarian Investing."
Known for his pioneering research on the seven "sparks" that trigger explosive profits in the small-cap sector.
Gifted researcher with 20 years' experience tracking bioscience and pharma stocks. Master of the FDA approval process.
Nationally recognized technical trader. Background in engineering, system designs, and risk reduction. 26 years in the markets.
Top money manager for 25 years. Leading credit market analyst. Best-known for calling the major recent global market moves.
Tom Gentile is one of the world's foremost authorities on stock, futures and options trading.
Silver prices have been sensitive to activities in the futures markets, with prices moving almost perfectly opposite to the amount of short contracts speculators hold.
This week, the U.S. Commodity Futures Trading Commission released data that shows that silver contracts are mounting coming off weekly lows.